|
|
Exchange: |
N/A |
Security
Type: |
N/A |
Shares
Out: |
24,270,000 |
Market
Cap: |
482.49(M) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$15.28 - $25.06 |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : 12.5 |
Insider 3/6 Months : 13.1 |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Fulgent Genetics is a holding company. Through its subsidiaries, Co. is a technology company providing COVID-19 testing services, molecular diagnostic testing services and genetic testing designed to provide physicians and patients with clinically actionable diagnostic information to improve the quality of patient care. Co. has developed a proprietary technology platform allowing Co. to provide a test menu. Combining next generation sequencing with its technology platform, Co. performs full-gene sequencing with deletion/duplication analysis in single-gene tests; pre-established, multi-gene, disease-specific panels; and customized panels that can be tailored to meet customer needs.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
100,000 |
100,000 |
100,000 |
Total Buy Value |
$0 |
$1,596,470 |
$1,596,470 |
$1,596,470 |
Total People Bought |
0 |
1 |
1 |
1 |
Total Buy Transactions |
0 |
1 |
1 |
1 |
Total Shares Sold |
4,801 |
4,801 |
20,137 |
67,485 |
Total Sell Value |
$98,136 |
$98,136 |
$419,107 |
$1,800,044 |
Total People Sold |
2 |
2 |
4 |
4 |
Total Sell Transactions |
4 |
4 |
16 |
29 |
End Date |
2025-03-30 |
2024-12-27 |
2024-06-28 |
2023-06-29 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Xie Jian |
President and COO |
|
2025-06-02 |
4 |
S |
$20.29 |
$23,030 |
D/D |
(1,135) |
371,496 |
|
5% |
|
Gao Hanlin |
Chief Scientific Officer |
|
2025-06-02 |
4 |
S |
$20.29 |
$15,299 |
D/D |
(754) |
961,281 |
|
5% |
|
Kim Paul |
CFO and Treasurer |
|
2025-06-01 |
4 |
D |
$20.72 |
$23,434 |
D/D |
(1,131) |
342,571 |
|
- |
|
Gao Hanlin |
Chief Scientific Officer |
|
2025-05-27 |
4 |
S |
$20.52 |
$21,339 |
D/D |
(1,039) |
962,035 |
|
3% |
|
Xie Jian |
President and COO |
|
2025-05-27 |
4 |
S |
$20.52 |
$38,468 |
D/D |
(1,873) |
372,631 |
|
3% |
|
Kim Paul |
CFO and Treasurer |
|
2025-05-26 |
4 |
D |
$20.31 |
$23,681 |
D/D |
(1,166) |
343,702 |
|
- |
|
Hsieh Ming |
Chief Executive Officer |
|
2025-05-26 |
4 |
D |
$20.31 |
$59,793 |
D/D |
(2,944) |
810,679 |
|
- |
|
Kim Paul |
CFO and Treasurer |
|
2025-05-23 |
4 |
D |
$20.31 |
$13,628 |
D/D |
(671) |
344,868 |
|
- |
|
Hsieh Ming |
Chief Executive Officer |
|
2025-05-23 |
4 |
D |
$20.31 |
$42,976 |
D/D |
(2,116) |
813,623 |
|
- |
|
Marsh Linda |
|
|
2025-05-15 |
4 |
A |
$0.00 |
$0 |
D/D |
8,982 |
27,641 |
|
- |
|
Groves Regina E |
|
|
2025-05-15 |
4 |
A |
$0.00 |
$0 |
D/D |
8,982 |
16,982 |
|
- |
|
Nohaile Michael |
|
|
2025-05-15 |
4 |
A |
$0.00 |
$0 |
D/D |
4,491 |
19,020 |
|
- |
|
Hsieh Ming |
Chief Executive Officer |
|
2025-05-01 |
4 |
D |
$17.25 |
$23,098 |
D/D |
(1,339) |
815,739 |
|
- |
|
Gao Hanlin |
Chief Scientific Officer |
|
2025-04-30 |
4 |
D |
$17.35 |
$1,371 |
D/D |
(79) |
963,074 |
|
- |
|
Gao Hanlin |
Chief Scientific Officer |
|
2025-04-26 |
4 |
D |
$18.88 |
$21,844 |
D/D |
(1,157) |
963,153 |
|
- |
|
Xie Jian |
President and COO |
|
2025-04-26 |
4 |
D |
$18.88 |
$82,185 |
D/D |
(4,353) |
374,504 |
|
- |
|
Kim Paul |
CFO and Treasurer |
|
2025-04-26 |
4 |
D |
$18.88 |
$51,788 |
D/D |
(2,743) |
345,539 |
|
- |
|
Kim Paul |
CFO and Treasurer |
|
2025-03-05 |
4 |
B |
$15.96 |
$1,596,470 |
D/D |
100,000 |
348,282 |
0.01 |
18% |
|
Xie Jian |
President and COO |
|
2025-03-01 |
4 |
D |
$15.45 |
$22,881 |
D/D |
(1,481) |
378,857 |
|
- |
|
Kim Paul |
CFO and Treasurer |
|
2025-03-01 |
4 |
D |
$15.45 |
$24,040 |
D/D |
(1,556) |
248,282 |
|
- |
|
Gao Hanlin |
Chief Scientific Officer |
|
2025-03-01 |
4 |
D |
$15.45 |
$15,218 |
D/D |
(985) |
964,310 |
|
- |
|
Kim Paul |
CFO and Treasurer |
|
2025-02-26 |
4 |
D |
$16.24 |
$75,711 |
D/D |
(4,662) |
249,838 |
|
- |
|
Xie Jian |
President and COO |
|
2025-02-26 |
4/A |
D |
$16.24 |
$73,908 |
D/D |
(4,551) |
380,338 |
|
- |
|
Hsieh Ming |
Chief Executive Officer |
|
2025-02-26 |
4 |
D |
$16.24 |
$191,194 |
D/D |
(11,773) |
817,078 |
|
- |
|
Gao Hanlin |
Chief Scientific Officer |
|
2025-02-26 |
4 |
D |
$16.24 |
$40,974 |
D/D |
(2,523) |
965,295 |
|
- |
|
362 Records found
|
|
Page 1 of 15 |
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Acquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|